Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials
- 30 September 2006
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 55 (3) , 537-538
- https://doi.org/10.1016/j.jaad.2006.05.030
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trialsThe Lancet Infectious Diseases, 2005
- Dosing With 5% Imiquimod Cream 3 Times per Week for the Treatment of Actinic KeratosisArchives of Dermatology, 2005
- Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histologyJournal of the American Academy of Dermatology, 2004
- Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsJournal of the American Academy of Dermatology, 2004
- A Randomized, Double-blind, Vehicle-Controlled Study to Assess 5% Imiquimod Cream for the Treatment of Multiple Actinic KeratosesArchives of Dermatology, 2002